Imran Nizamudin Alibhai's most recent trade in Tvardi Therapeutics Inc. was a trade of 182,320 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on April 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Imran Nizamudin Alibhai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 182,320 | 182,320 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Imran Nizamudin Alibhai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 207,881 | 207,881 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Imran Nizamudin Alibhai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 160,940 | 160,940 | - | - | Employee Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Imran Nizamudin Alibhai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 2,011 | 2,011 | - | - | Employee Stock Optyion (right to buy) |